Theme: Enrich the Endeavors in Gynecologic Cancer Care

Gynecologic Cancer 2018

Renowned Speakers

Gynecologic Cancer 2018

ConferenceSeries LLC.Ltd invites to all the participants around the globe to “International Conference on Frontiers in Gynecologic Cancers” scheduled during November 7-8, 2018, Singapore with a theme Enrich the Endeavors in Gynecologic Cancer Care which includes prompt Keynote presentations, Oral talks and Poster presentations, Workshops, Video Presentations and Exhibitions.

Gynecologic Cancer 2018 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation

This Gynecologic Cancer Conferences provides a gathering of trade of knowledge among researchers, doctors and oncologists to introduce and Presentation about their Constructive, observational test or hypothetical work in each part of Gynecologic Cancer hence redesigning the quality and organizations to the relevant research thus redesigning the standard and organizations to the relevant analysis works.

Opportunities for Academic Attendees (For Researchers &Faculty)

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing
  • Video Presentation

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group Participation

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients

Why to Attend??

With members from around the world focused on learning about Frontiers in Gynecologic Cancers; this is your best opportunity to reach the largest assemblage of participants from the Gynecologist and Women’s Health community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the gynecology cancer treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in, Gynecologic cancer, women’s health, gynecological issues, pregnancy, Woman Psychology, women disorders are hallmarks of this conference.

 

Target Audience:

Gynecologic Cancer 2018 is intended for:

  • Gynecologists
  • Obstetricians
  • Gynecologic Oncologists
  • perinatologists
  • Breast cancer surgeon
  • Gynecology Surgeons
  • IVF Specialists
  • Scientists and Professors
  • Nurses/ Midwives
  • Students
  • Business Entrepreneurs
  • Training Institutes
  • Data Management Companies
  • Software Developing Companies  
  • Medical Devices Manufacturing Companies

TRACK 1. GYNECOLOGIC ONCOLOGY

As many Gynecological conferences and meetings worldwide, it states that around 80,000 women are diagnosed with gynecologic cancers in the USA, and half of the people were uterine cancer diagnosed with deaths of 8,000 women per yearOvarian cancer is found to be the 2nd most common gynecologic cancer with around 22,000 new cases every year, leading to 16,000 deaths per year. Mortality of cases in cervical cancer have been decreased as Pap smears have become common in place. However, there are about 12,000 diagnoses every year in which about 4,200 women die from this disease every year. Vulvar and vaginal cancer are comparatively rare and when diagnosed and treated early it offers good prognosis. 4,500 women are being diagnosed with vulvar cancer each year, in which there is about 950 deaths among them. Vaginal cancer account for about 2,600 diagnoses each year causing about 840 deaths. Every woman is at risk for augmenting a gynecologic cancer. It is calculated that there will be around 98,000 new cases diagnosed and approximately causing 30,000 deaths from gynecological cancers in the USA during the year 2015 stated as per The American Cancer Society, in which Uterine cancer may have the large portion of about 50% cases with an estimated mortality rate of approximately 18.5%. The Ovarian cancer has the highest estimated mortality rate at 66%.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

 

 TRACK 2. GYNECOLOGY & OBSTETRICS

 Gynecology and obstetrics are the studies of the female reproductive system. Obstetrics is the branch of medicine that focuses on women during pregnancy, childbirth, and the postpartum period. Gynecology is a broader field, focusing on the general health care of women and treating conditions that affect the female reproductive organs. Doctors who are specialized in gynecology and obstetrics will have to undergo four years of post-medical school training in the areas of women’s general health, pregnancy, labor and delivery, preconception and postpartum care, prenatal testing, and genetics. For example, women may be referred as gynecologists in the earlier stages of pregnancy, and obstetricians later in their term.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

 TRACK 3. OVARIAN CANCER

Ovarian Cancer is a kind of tumor that begins in the ovaries. The female reproductive system contains two ovaries, one on each side of the uterus. The ovaries — each about the extent of an almond — make eggs (ova) and the hormones estrogen and progesterone.

Ovarian cancer consistently goes undetected until the point that it spread inside the pelvis and stomach area. At this late stage, an ovarian cancer is harder to treat and is a significant part of the time deadly. Starting time ovarian cancer, in which the ailment is constrained to the ovary, will probably be dealt with effectively

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 4.  CERVICAL CANCER

Cervical cancer is a cancer arises from the cervix. It is due to the abnormal growth of cells that can invade or spread to other parts of the body. Early on, typically no symptoms are seen. Later symptoms may include abnormal vaginal bleedingpelvic pain, or pain during sexual intercourse. While bleeding after sex may not be serious, it may also indicate the presence of cervical cancer.

Cervical cancer typically develops from precancerous changes over 10 to 20 years. About 90% of cervical cancer cases are squamous cell carcinomas, 10% are adenocarcinoma, and a small number are other types. Diagnosis is typically by cervical screening followed by a biopsy. Medical imaging is then done to determine whether the cancer has spread.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

 TRACK 5. FALLOPIAN TUBE CANCER

The clinical introduction of Fallopian Tube Cancer is fundamentally the same as ovarian disease and PPC, however there are a few contrasts. Cancers of the fallopian tube emerge inside within (lumen) of the fallopian tube and ordinarily make it swell like a sausage. The association of the ovary is secondary, however, it is typically so broad that one can't tell whether it started on the ovary and spread to the fallopian tube or the other way around. Therefore, numerous fallopian tube cancers may have been named ovarian cancer. As the fallopian tube swells with malignancy, it produces liquid, like ascites, that can "spill" over into the uterus and prompt a watery vaginal release, the exemplary introduction of FTC when related with an adnexal mass.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 6. UTERINE CANCER

Uterine Cancer, otherwise called womb cancer, is any sort of cancer that rises up out of the tissue of the uterus. It can allude to a few kinds of tumor, with cervical cancer (emerging from the lower segment of the uterus) being the most widely recognized write worldwide and the second most cancer in women in developing nations. Endometrial Cancer (or cancer of the inner lining of the uterus) is the second most basic compose, and fourth most basic cancer in women from created nations. Risk factors rely upon the particular kind, however, obesity, older age, and human papillomavirus infection include the most danger of treating uterine cancer. At an opportune time, there might be no symptoms, yet unpredictable vaginal bleeding, pelvic pain or fullness may develop. If caught early, most types of uterine cancer can be cured using surgical or medical methods. When the cancer has extended beyond the uterine tissue, more advanced treatments including combinations of chemotherapy, radiation therapy, or surgery may be required.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

  TRACK 7. VAGINAL CANCER

Vaginal Cancer is an illness in which threatening (tumor) cells shape in the vagina.

Age and being presented to the medication DES (diethylstilbestrol) before birth influence a woman's risk of vaginal cancer.

Signs and side effects of vaginal cancer include pain or abnormal vaginal cancer.

Vaginal cancer isn't normal. There are two fundamental kinds of vaginal cancer:

Squamous cell carcinoma: Cancer that structures in squamous cells, the thin, level cells covering the vagina. Squamous cell vaginal growth spreads gradually and ordinarily remain close to the vagina, however, may spread to the lungs, liver, or bone. This is the most widely recognized sort of vaginal growth.

Adenocarcinoma: Cancer that starts in glandular cells. Glandular cells in the coating of the vagina make and discharge liquids, for example, bodily fluid. Adenocarcinoma is more probable than squamous cell growth to spread to the lungs and lymph hubs. An uncommon sort of adenocarcinoma is connected to being presented to diethylstilbestrol (DES) before birth. Adenocarcinomas that are not connected with being presented to DES are most regular in ladies after menopause.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 8. ENDOMETRIAL CANCER

Endometrial Cancer is a tumor that emerges from the endometrium (the coating of the uterus or womb). It is the consequence of the abnormal development of cells that can attack or spread to different parts of the body. The primary sign is frequently vaginal draining not related with a menstrual period. Different indications incorporate agony with pee, torment amid sex, or pelvic torment. Endometrial growth happens most normally after menopause.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 9. VULVAR CANCER

Vulvar Cancer is a kind of disease that happens on the external surface zone of the female genitalia. The vulva is the area of skin that encompasses the urethra and vagina, including the clitoris and labia.

Vulvar Cancer usually frames as an irregularity or sore on the vulva that regularly causes itching. Even though it can happen at any age, vulvar Cancer is most normally analyzed in older adults more.

Vulvar cancer treatment, as a rule, includes surgery to evacuate the tumor and a little measure of encompassing solid tissue. At times vulvar disease surgery requires evacuating the whole vulva. The prior vulvar cancer is analyzed, the more outlandish a broad surgery is required for treatment.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 10. CHRONIC PELVIC PAIN

Pelvic pain is found between the belly button and the hips and groin. If it lasts for 6 months or more it is called chronic pelvic pain Chronic pelvic pain typically accustomed describes the persistent pain felt in very woman’s fruitful organs. It’s a big and customary drawback which will influence any lady, in spite of age typically times, the etiology is unclear, and therefore the pain generally lasts for months. Researchers aren’t bound concerning the quantity of ladies within the united states un agency have chronic girdle pain, however some studies have reportable that up to 15% of ladies of childbearing age have experienced it. Worldwide, this ranges from 14–32%. In 32% of affected girls, the pain is therefore severe that they must miss work.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 11. UROGYNECOLOGY

Urogynecology is an extensive topic and is professional in gynecology and the number of Research institutes working on the Urogynecology are approximately 30 or more and some universities also give training to women on Urogynecology, total number of universities which focus on this area are approximately 70 and also obtain a funding of around $10000- $30000 and includes 10% industry, 30% of academia and Others 60% .It is a surgical sub-specialty of urology and gynecology. Uro gynecology involves  diagnosis and treatment of urinary incontinence and female pelvic floor disorders. Urogynecology is also a subspecialty of Female Pelvic Medicine and Reconstructive Surgery. Robotic-assisted surgery has evolved vastly over the past two decades with persistently improving technology, proving to assist surgeons in multiple subspecialty disciplines as discussed in many gynecologic conferences and gynecologic meetings worldwide.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 12. GYNECOLOGIC SURGERY

Gynecologic Surgery is giving a data for clinical articles managing all parts of agent and office gynecology. "Gynecological surgery ", established in 2004, is the first and head peer-surveyed logical diary devoted to all parts of research, advancement, and preparing in gynecological surgery.   Gynecological surgery alludes to surgery on the female conceptive framework. It incorporates strategies for amiable conditions, malignancy, fruitlessness, and incontinence. Gynecological surgery may once in a while be performed for elective or restorative purposes. Also, this field is quickly changing because of new advancements and developments in endoscopy, apply autonomy, imaging and other interventional systems. Gynecological surgery is presently develops every surgical intercession relating to ladies’ wellbeing, including urogynecology, oncology and fetal surgery.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 13. INFERTILITY

Infertility can be depicted as a lady who can't imagine and being unable to convey a pregnancy in full term. Infertility is the failure of a man, plant or a creature to repeat by normal means. It is regularly not the natural condition of a sound grown-up creature, with the exception of in especially among certain social species Understanding the socio statistic factors parallel with utilize may help recently wedded couples with family arranging. As examined in numerous gynecologic gatherings and gynecologic gatherings around the world, the utilization of infertility administrations is not irregular and generally around half of the ladies assessed for Infertility advanced to treatment, and in which just a little extent were treated with extra progressed helped conceptive innovations basically Ladies who are prolific will encounter a characteristic time of richness earlier and amid ovulation, and they will be actually infertile amid the last piece of the menstrual cycle. Therapeutic and surgical administration of substantial menstrual draining is portrayed including the many changed issues in hysterectomy of obese women.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 14. WOMEN'S SEXUAL HEALTH

Sexual health alludes to a condition of well-being that lets a woman completely take part in and appreciate the sexual action. A scope of physical, mental, interpersonal, and social elements impact a womans sexual health.

For some woman, contraception is an imperative part of sexual health. Another is maintaining a strategic distance from sexually transmitted diseases. These incorporate gonorrhea, syphilis, genital herpes, chlamydia, human papillomavirus, and HIV/AIDS. Utilizing a condom is a key method to ensure against getting a sexually transmitted contamination.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 15. OVARIAN CYST

The ovaries are a part of the female reproductive system. They're situated in the lower abdomen on both sides of the uterus. Women have two ovaries that produce eggs and in addition the hormones estrogen and progesterone.

Occasionally, a liquid filled sac called a cyst will develop on one of the ovaries. Many women will develop at least one cyst during their lifetime. Much of the time, cysts are easy and cause no side effects.

Most ovarian cysts are benign and normally leave individually without treatment. These cysts cause pretty much nothing, assuming any, side effects. Be that as it may, in an uncommon case, specialist may identify a cancerous cystic ovarian mass amid a standard examination.

Ovarian torsion is another uncommon complexity of ovarian cysts. This is when a large cyst causes an ovary to twist or move from its original position. Blood supply to the ovary is cut off, and if not treated, it can make harm or demise the ovarian tissue. Albeit exceptional, ovarian torsion represents almost 3 percent of emergency gynecologic surgeries.

Ruptured cysts, which are additionally uncommon, can cause extreme torment and inner dying. This inconvenience builds the danger of a contamination and can be dangerous if left untreated.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 16. EARLY PREGNANCY LOSS

Early pregnancy loss is characterized as a nonviable, intrauterine pregnancy with either an exhaust gestational sac or a gestational sac containing a developing embryo or fetus without fetal heart movement inside the initial 12 6/7 weeks of gestation. In the first trimester, the terms miscarriage, spontaneous abortion, and early pregnancy loss are used interchangeably, and there is no consensus on terminology in the literature.

Early pregnancy loss is common, happening in 10% of all clinically perceived pregnancies. Around 80% of all instances of pregnancy loss happen within the first trimester.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 17. INVITRO FERTILIZATION

IVF is a kind of assisted reproductive technology utilized for Infertility treatment and surrogacy. Today, the logical term "in vitro" is utilized to allude to any natural system that is performed outside the living being in which it would ordinarily have happened, to recognize it from an in vivo methodology, where the tissue stays inside the living life form inside which it is regularly found. A casual term for babies considered as the aftereffect of IVF, "unnaturally conceived children", alludes to the tube-formed holders of glass or plastic tar, called test tubes, which are generally utilized as a part of science labs and science labs. In any case, IVF is typically performed in the shallower compartments called Petri dishes. One IVF strategy, autologous endometrial Coculture, is really performed on natural material, yet is yet considered IVF.

Women who have been already pregnant are much of the time more fruitful with IVF medicines than the individuals who have never been pregnant. Due to progresses in Reproductive Technology, IVF achievement rates are generously higher today than they were only a couple of years prior.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 18. PRENATAL NUTRITION

Prenatal nutrition addresses nutrient recommendations before and during pregnancy. Prenatal nutrition has a strong influence on birth weight and further development of the infant

Maintaining a healthy weight during gestation lowers adverse risks on infants such as birth defects, as well as chronic conditions in adulthood such as obesitydiabetes, and cardiovascular disease.

Nutrition and weight management before and during pregnancy has a profound effect on the development of infants. 

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 19.  PRIMARY PERITONEAL CANCER TREATMENT

Primary Peritoneal Cancer (PPC) is a moderately uncommon tumor that grows most generally in women. PPC is a close relative of epithelial ovarian cancer, which is the most widely recognized kind of malignancy that affects the ovaries. The reason for Primary Peritoneal Cancer is obscure.

It is imperative for women to realize that it is conceivable to have Primary Peritoneal Cancer regardless of whether their ovaries have been removed.

It creates in a thin layer of tissue that lines the abdomen. It additionally covers the uterus, bladder, and rectum. Made of epithelial cells, this structure is known as the peritoneum. It creates a liquid that enables organs to move easily inside the guts.

Because of the disseminated nature of the disease, primary peritoneal cancer is treated with surgical debulking and chemotherapy. Women with any stage of primary peritoneal cancer should be considered for a clinical trial.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 20. RADIATION THERAPY IN GYNECOLOGY

Radiation therapy is an essential component in Gynecology in the primary nonsurgical management and the adjuvant postoperative treatment of selected malignancies arising in the female reproductive tract. Gynecologic cancers were among the first malignancies treated with ionizing radiation. Primary radiotherapy can provide a chance for cure for women with unresectable, locally advanced disease or for those women with medical risk factors that contraindicate primary surgical therapy. Unfortunately, for women with distant metastatic disease at presentation, disease cure is unlikely. Palliative radiotherapy can frequently improve a patient's quality of life when used for the relief of symptoms. Although adjuvant radiotherapy is commonly used for advanced or metastatic cervical and endometrial cancer, it is infrequently employed as adjuvant therapy for ovarian cancer. Radiation therapy may be also be used for hormonal ablation.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 21. GYNECOLOGY CANCER PREVENTION AND CONTROL

Surgery is the removal of the tumor and surrounding tissue during an operation. A surgical oncologist is a doctor who specializes in treating cancer using surgery. A hysterectomy is the removal of the uterus and cervix

Radiation therapy is the use of high-energy x-rays or other particles to destroy cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a Radiation Oncologist. Radiation therapy may be given alone, before surgery, or instead of surgery to shrink the tumor. Many women may be treated with a combination of radiation therapy and chemotherapy.

 Chemotherapy is the use of drugs to destroy cancer cells, usually by stopping the cancer cells ability to grow and divide. Chemotherapy is given by a medical oncologist, a doctor who specializes in treating cancer with medication. Systemic chemotherapy is delivered through the bloodstream to reach cancer cells throughout the body. Common ways to give chemotherapy include an intravenous (IV) tube placed into a vein using a needle or in a pill or capsule that is swallowed (orally).

Another avenue of immunotherapy for Gynecologic and cervical cancers is adoptive T cell transfer. In this approach, T cells are removed from a patient, genetically modified or treated with chemicals to enhance their activity, and then re-introduced into the patient with the goal of improving the T cell immune system’s anti-cancer response.

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 22. GYNECOLOGY NURSING AND MIDWIFERY

With the current challenges in the healthcare system, patients and professionals are uncertain about the role, responsibilities, and communication patterns of primary care professionals during cancer care. Oncology and primary care nurses should be surveyed to attain current and preferred roles in cancer care across the care continuum. 

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

TRACK 23. GYNECOLOGY CANCER: CASE REPORT

Ladies with early cervical cancer and pre-diseases often have no manifestations. Manifestations regularly don't start until a pre-tumor turns into a genuine intrusive disease and develops into adjacent tissue. At the point when this happens, the most widely recognized manifestations are: Abnormal vaginal dying, for example, seeping after sex (vaginal intercourse), seeping after menopause, draining and spotting amongst periods, and having longer or heavier (menstrual) periods than common. Seeping in the wake of douching, or after a pelvic exam is a typical side effect of cervical tumor however not pre-disease. A strange release from the vagina − the release may contain some blood and may happen between your periods or after menopause; Pain amid sex (vaginal intercourse).

Recommended Gynecology Conferences | Gynecologic Cancer Conferences | Oncology Meetings | ConferenceSeries llc.LTD

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018, Japan;4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics , July 18-19, 2018 ,USA ; 6th International Congress on Gynecology & Gynecologic Oncology , July 23-24, 2018 ,Italy ; 17th Biennial Meeting of the International Gynecologic Cancer Society , September 14-16, 2018,Japan; EuroSciCon Conference on Gynecologic Oncology, Oct 29-30, 2018 , Hungary ; 2nd International Conference on Obstetrics and Gynecology, June 21-23, 2018 ,UK ; 5th International Conference on Gynecology and Obstetrics, October 08-10, 2018, Switzerland.

Related Associations:

Society of Gynecologic Oncology, USA ; European Society of Gynaecological Oncology, Europe; American Association for Cancer Research , USA ; Association of Gynecologic Oncologists of India , India ; International Gynecologic Cancer Society , United States; Indonesian Society of Gynecologic Oncology ,Indonesia ; British Gynaecological Cancer Society, UK ; Japan Society of Gynecologic and Obstetric Endoscopy , Japan ; The Society of Obstetricians and Gynaecologists of Canada , Ottawa ; International Federation of Gynecology and Obstetrics , UK ;  Obstetrical & Gynecological Society of Singapore , Singapore ; EJOG-AJOG OBSTETRICS RESOURCE CENTRE, Netherlands

Summary:

Gynecologic Cancer is the field of medicine that focuses on cancers of the female generative system, including vaginal cancer, ovarian cancer, cervical cancer, uterine cancer. As experts, they have wide training in the diagnosis and treatment of these cancers.

Although the occurrence and mortality from endometrial and ovarian cancer are major, other cancers are very uncommon. Primary cancers of the vulva, vagina, placenta, and adnexa total 0.6% of all woman cancers.

Gynecologic Cancer Statistics :

In the world, 82000 women are identified with Gynecologic cancer each year. In 2013, an expected 91,730 were diagnosed.

An estimated 88,000 new cases of Gynecologic cancer were expected to be diagnosed in 2014 in the U.S.A, and over 29,000 American females will lose their battle with this deadly disease. In addition to imposing a significant load on patients and their relations, Gynecologic cancer places a major burden on the healthcare organization. Despite advances in cancer care in the United States, cancer-related diseases and death for advanced and recurrent Gynecologic malignancies remain at intolerable stages.  Endometrial cancer has seen a slight rise in both new cancer incidents and annual death rates over the past 30 years. Every woman is at risk for emerging a Gynecologic Cancer.

Accounting for 3% of all cancers in women and figuring more than 165,000 new cases estimated in2013, ovarian cancer is the sixth most common female cancer and the sixth prominent cause of death in women globally. In Canada, ovarian cancer accounts for 4% of all female cancers or 31%ofall genital cancers in women, it is estimated that in 2014 there were 2,500 new cases and 1,500 deaths

There is a large variation in incidence rates of ovarian cancer worldwide, from 3/100,000 in central Africa to 13/100,000 in northern Europe. Developing nations have incidence rates that are nearly half those of the most resource-rich countries.

Scope and Importance of Gynecologic Cancer :

Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years old.

Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Tumor biology early detection, and treatment of ovarian cancer in older women as compared to younger women suffering from this malignancy. The effort was devoted to the type of problems met in conducting the analyses and, where data were inadequate, recommending research guidelines or approaches.

The center is at the forefront of research in the early discovery of ovarian cancer and uterine cancer, which is involved in developing blood tests to precisely determine the absence or presence of early-stage ovarian cancer before it reveals, as well as ongoing translational research programs for all Gynecologic Cancers.  Physicians are also involved in leading-edge programs in the prevention of cervical cancer through regular screenings and the identification of precancerous cervical lesions associated with papillomavirus infections.

Organized screening procedures can support to detect Gynecologic Cancer, including cervical cancer, uterine cancer, and ovarian cancer, early.

Hospitals Associated with Gynecologic Cancer in Singapore:

·         Gynaecology & Oncology Specialists

·         Lisa Wong Women & Gynae Oncology Centre

·         National Cancer Centre Singapore

·         Parkway Cancer Centre - Mount Elizabeth Hospital

·         National University Cancer Institute, Singapore

·         Raffles Cancer Centre

·         Asian American Radiation & Oncology

·         Mount Elizabeth Hospital

·         Johns Hopkins Singapore

·         Thomson Women Cancer Centre

·         Singapore Cancer Society Rehabilitation Centre

·         Concord International Hospital

·         Maternity & Gynaecological Clinic

·         H L Kong Medical Oncology Centre - Novena Medical Center

·         Singapore Cancer Society Satellite Centre @ NCIS

·         SOG - Heng Clinic For Women

·         Gleneagles Hospital

·         KK Women's and Children's Hospital

·         SOG - Natalie Chua Clinic for Women

·         Women Fertility & Fetal Centre: Dr Ann Tan – IVF

·         Anne Hagarty

·         Dr Karmen Wong

·         Seed of Life, Fertility & Women's Care Medical Centre Pte Ltd

·         Acufem Women's Specialist Services – Gleneagles

·         International Urology, Fertility & Gynaecology Centre: Dr. Michael Wong – Urologist

·         My Gynae Women's Clinic

·         Irene Chua Clinic for Women

Gynecological Cancer Drugs Market Overview:

The Global Gynecological Cancer Drugs Market size was valued at $9,269 million in 2016 and is expected to reach $16,107 million by 2023, growing at a CAGR of 8.1% from 2017 to 2023.

Cancer refers to a specific group of disorder, which leads to abnormal cell growth within any part of the body. Gynecological cancer refers to a group of cancers that affect the reproductive organs of a female such as a uterus, endometrium, ovary, peritoneum, fallopian tubes, vagina, vulva, cervix, and muscle & tissue supporting the uterus.

The growth of the global gynecological cancer drugs market is driven by factors such as an increase in incidence of gynecological cancers, growth in importance of targeted drug therapies, rise in investment from government, public & private organizations for the development of novel drugs to treat cancer, and increase in risk factors that lead to cancer. However, the high cost of drug development and the threat of failure & adverse effects of cancer drug therapy restrain the growth of the market. Conversely, advancement of cancer drug research and the advent of personalized medicine approach are expected to provide lucrative opportunities for the market expansion during the forecast period.

Gynecological Cancer Drugs Market Segmentation

The global gynecological cancer drugs market is segmented on the basis of therapeutic modality, indication, and region. Based on therapeutic modality, the market is divided into chemotherapy, targeted therapy, and hormonal therapy. The indications segment is categorized into uterine cancer, ovarian cancer, vaginal & vulvar cancer, and cervical cancer. Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment Review

Chemotherapy segment accounted for the largest market share in 2016 and is expected to maintain this trend throughout the forecast period. In recent years, combination chemotherapy is considered as a standard treatment mode for treatment of cancer due to its effectiveness in an increase in survival & remission rates. For instance, the combination therapy of gemcitabine with a platinum compound produced high response rates (as high as 71%) in patients suffering from ovarian cancer. Similarly, gemcitabine is used in combination with other compounds and cytotoxic agents for the effective treatment of ovarian cancer. Popular combinations include gemcitabine with a platinum compound and paclitaxel and gemcitabine with cisplatin or carboplatin. However, the standard approach of combination chemotherapy for treatment of epithelial ovarian cancer includes a combination of a platinum compound, such as cisplatin or carboplatin, and a taxane, such as paclitaxel (Taxol) or docetaxel (Taxotere).

Snapshot of LAMEA Gynecological Cancer Drugs Market

A rise in the focus of vendors on emerging markets, such as Asia-Pacific and LAMEA, is expected to boost the market growth. Currently, multinational companies are focusing on investing in the GCC region as well as Latin America and Africa to expand their global reach and gain a competitive advantage. To reduce the burden of cancer, GCC member countries have established the Gulf Centre for Cancer Control and Prevention (GCCCP) that supports, services, and organizes programs for cancer control. In addition, it provides support services for the implementation of high-quality treatment care at all healthcare facilities in GCC states. GCCCP promotes cancer research in GCC member states through funding and collaboration with cancer research organizations.

Clinical Trials:

Gynecological cancer drugs market has witnessed several clinical trials (5,920 trials) in the recent years, owing to increase in cancer prevalence and surge in demand for advanced healthcare facilities. Cervical cancer drugs accounted for the maximum number of trials (2,561) in the global market. In addition, North America accounted for the maximum number of trials (3,353 trials) in the global market, followed by Europe (1,156 trials).

Clinical Trials for Gynecological Cancer Drugs, by Cancer Type (%)

 

The list of key players profiled in this report include Apotex Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.

  • It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

  • Analysis by therapeutic modality helps to understand the various types of treatment modalities for the treatment of gynecological cancer patients.

  • Comprehensive analysis of all geographical regions is provided, which helps in determining the prevailing opportunities.

  • Key players are profiled and their strategies are analyzed thoroughly, which helps to understand the competitive outlook of the global market.

Gynecological Cancer Drugs Market Key Segments:

By Therapeutic Modality

  • Chemotherapy

  • Targeted Therapy

  • Hormonal Therapy

By Indication

  • Uterine Cancer

  • Ovarian Cancer

  • Vaginal & Vulvar Cancer

  • Cervical Cancer

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • Japan

  • China

  • Australia

  • India

  • South Korea

  • Rest of Asia-Pacific

  • Brazil

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

  • Asia-Pacific

  • LAMEA

Societies Associated with Gynecologic Cancer :

In the world there are about 9,685 societies which are specifically associated with Gynecologic Oncology:

  • American gynecological and obstetrics society
  • American society of clinical oncology
  • National cancer institute
  • Society of Gynecologic Oncology
  • Society of Gynecologic Nurse Oncologists
  • International Gynecologic cancer society
  • American College of Phlebology
  • American Congress of Obstetricians and Gynecologists
  • Asian Society of Gynecologic Oncology
  • Female Genital Tract Pathology
  • Foundation for Women's Cancer
  • GYN-ONC - Gynecologic Cancers Support Group
  • Northern Gynecologic Oncology Centre
  • Queensland Centre for Gynecologic Oncology 

Industries Associated with Gynecologic Oncology Research

Industries associated with Gynecologic cancer over all the world are

·        Johnson & Johnson

·        Novartis

·        Roche

·        Pfizer

·        Sanofi

·        Merck

·        Bristol-myers squibb

·        Eli Lilly

·        Celgene

·        Takeda

·        AstraZeneca

·        Merck & Co.

·        Amgen

·        Bayer

·        Otsuka

·        Pharmacyclics

·        Incyte

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 07-08, 2018
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View

Media Partners